Version 1
: Received: 28 July 2023 / Approved: 31 July 2023 / Online: 1 August 2023 (09:47:56 CEST)
How to cite:
Borcan, F.; Vlase, T.; Vlase, G.; Popescu, R.; Soica, C.M. Synthesis and Assessment of a Polyurethane Carrier Used for the Transmembrane Transfer of 2'-Deoxycytidine-5'-monophosphate sodium salt. Preprints2023, 2023080025. https://doi.org/10.20944/preprints202308.0025.v1
Borcan, F.; Vlase, T.; Vlase, G.; Popescu, R.; Soica, C.M. Synthesis and Assessment of a Polyurethane Carrier Used for the Transmembrane Transfer of 2'-Deoxycytidine-5'-monophosphate sodium salt. Preprints 2023, 2023080025. https://doi.org/10.20944/preprints202308.0025.v1
Borcan, F.; Vlase, T.; Vlase, G.; Popescu, R.; Soica, C.M. Synthesis and Assessment of a Polyurethane Carrier Used for the Transmembrane Transfer of 2'-Deoxycytidine-5'-monophosphate sodium salt. Preprints2023, 2023080025. https://doi.org/10.20944/preprints202308.0025.v1
APA Style
Borcan, F., Vlase, T., Vlase, G., Popescu, R., & Soica, C.M. (2023). Synthesis and Assessment of a Polyurethane Carrier Used for the Transmembrane Transfer of 2'-Deoxycytidine-5'-monophosphate sodium salt. Preprints. https://doi.org/10.20944/preprints202308.0025.v1
Chicago/Turabian Style
Borcan, F., Roxana Popescu and Codruta M Soica. 2023 "Synthesis and Assessment of a Polyurethane Carrier Used for the Transmembrane Transfer of 2'-Deoxycytidine-5'-monophosphate sodium salt" Preprints. https://doi.org/10.20944/preprints202308.0025.v1
Abstract
The drug delivery systems receive more and more attention for the control and treatment of many diseases due to their increased number in recent years. The main aims of this study were to develop and to characterize a polyurethane drug delivery system that it is intended to be used for the transmembrane transport of nucleosides. Three different samples have been synthesized based on aliphatic diisocyanates (hexamethylene diisocyanate, isophorone diisocyanate and lysine diisocyanate) as organic phase, respectively a mixture of polyethylene glycol, polycaprolactone diol and low molecular weight diols as aqueous phase. The samples were characterized by pH, refractivity index and solubility measurements, drug loading efficacy and release investigations, thermal behavior, Zetasizer, cells viability and irritation tests on mice skin. The results indicate the obtaining of different populations of neutral acido-basic particles with size between 132 and 190 nm; the Zeta potential values and SEM images show a medium tendency to form clusters, while UV-Vis evaluations indicate an almost 70% encapsulation efficacy, a prolonged release (45% of encapsulated substance is released in the first 5 days) and around 70% of particles have penetrated an artificial membrane in the first 24h. The synthesized products can be tested in further clinical trials, the currently tests on cells culture and mice skin revealing no side effects.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
